Cardiovascular Device & Diagnosis Market

January 2011 | 42 pages | ID: C62D0464A3BEN
Ken Research Private Ltd

Abstracts

The year 2010 brought opportunities and hope for many industries to overcome from the effect of recession although medical equipment industry was not affected much compared to others due to necessity of the treatment. Cardiovascular device market also faced the heat of the economic downturn but managed to generate positive results with a slow growth rate and increased M&A activities to compete in the tough situations. There are two sub-segments accounting for high demand, Cardiac rhythm management and cardiovascular monitoring and diagnostic devices.

In terms of geography, United States represents the largest market in the worldwide cardiovascular disease diagnostics market. Europe represents the second largest market, followed by Japan. The US National Health expenditures have grown from 2004 to reach US$~ billion in 2009. According to an American Heart Association, cardiovascular disease (CVD) and death rates is expected to rise in China by nearly 73% by 2030 Cardiovascular product sales are estimated to increase attesting to the large opportunities in China. Growth in medical device sector offers room to grow for cardiovascular device demand in the region.

Report Highlights

• The overall sales in the global market for cardiovascular devices in 2009 amounted to US$~ billion, while the projected sale for 2010 is an estimated US$~ billion. At a compound annual growth rate of 2.8 %.
• Sales in diagnostic cardiovascular devices amounted to US$~ billion in 2009. This is estimated to reach to US$~ billion in 2015 with a CAGR of 4.50%.
• In 2008, World cardiovascular in-vivo diagnostics market was estimated to US$~ billion.
• The worldwide CRM market, including Electrophysiology, approximated US$~ billion in 2009, as compared to US$~ billion in 2008 and US$~ billion in 2007 with a growth rate of 15.38%.
• In US, the total number of heart related implant procedures was 2.2 million in 2009 based on the profits of 2.3% every year from 2004. Stenting procedures accounted for approximately 53% of the total in 2009.
• Cardiac implant accounts for nearly ~% of the total implantable medical device industry in US. Demand for cardiac implants is projected to grow at a 7 year CAGR of 6.72% to ~.0 billion in 2015.
• Rising rates of obesity have also contributed to the increase in Heart attack rates. Over the past 13 years, the percent of the U.S. population classified as obese has increased 67% (from 15.9% of the population in 1995 to 26.6% in 2008).

Scope of the report

• The report provides all the crucial company information required for business and competitor intelligence needs.
• Contains a study of the major internal and external factors affecting the industry in the form of industry trends and examination of leading industry players.
• Data is supplemented with details on the industry past performance, present analysis and future projections; also opportunities present in many countries.
• The present report analyse the industry performance and reasons of changes in growth rates with future projection using dependent and independent variables with the help of tools like SPSS.
• Report has covered a section of driving forces which helps to understand the present performance and impact over future.

Contents

1. CARDIOVASCULAR DISEASE AND DEVICES DEFINITION

1.1 History of Cardiovascular Devices

2. GLOBAL MARKET SIZE AND DEVELOPMENT

2.1 Cardiovascular Device and Diagnosis Market
2.2 Cardiac Rhythm Management (CRM)
2.3 Future Outlook

3. UNITED STATES CARDIOVASCULAR DEVICE MARKET AND OPPORTUNITIES

3.1 Healthcare Overview
3.2 US Cardiovascular Disease Prevalence and Mortality Rates
3.3 Cardiac Implant Devices
  3.3.1 Cardiac Implant Market and Forecast
3.4 Potential Market for Implantable Medical Devices
3.5 US Major Players Market Share

4. ASIA PACIFIC CARDIOVASCULAR DEVICE MARKET AND OPPORTUNITIES

4.1 Australia Cardiovascular disease and Prevalence Trends
  4.1.1 Healthcare Statistics
  4.1.2 Ageing Population
4.2 China Cardiovascular disease Prevalence and Device Market
  4.2.1 CVD Death Rates
  4.2.2 Prevalence of Heart Disease
  4.2.3 Opportunities in China Medical Device Industry
4.3 Prospects in Hong Kong Cardiovascular Industry

5. INDUSTRY DRIVING FORCES

5.1 Affluent Customers in Indian Cardiovascular industry
5.2 Introduction of New Tools and Devices
5.3 Rising Healthcare expenditures
5.4 Favouring Disposable Income in Developing Countries
5.5 Health Problems Leading Demand for Medical Treatment
5.6 Intensifying Hospital Supplies with Growing Elderly World Population
5.7 Rising Rate of Obesity
5.8 Rising Per Capita Income

6. INDUSTRY TRENDS AND DEVELOPMENTS

6.1 M&A Deals would drive the demand in coming Years
6.2 Neurovascular Device Industry to Grow
6.3 Impact of Lifestyle on Cardiovascular Health
6.4 Impact of Recession over Cardiovascular Device Industry
6.5 Trends in Polymer Heart Valve Market
6.6 The cost of cardiovascular disease
6.7 Drop in Demand for Cardio Monitoring Device
6.8 Drop in Heart attack rates in California
6.9 Demand for Medical Equipments and Devices in Italy

7. COMPANY PROFILES

7.1 Medtronic Inc
  7.1.1 Business Overview
  7.1.2 Financial Performance
  7.1.3 Business Strategies
7.2 Boston Scientific
  7.2.1 Business Overview
  7.2.2 Financial Performance
  7.2.3 Business Strategies

List Of Figures

LIST OF FIGURES

Figure: Global Cardiovascular Market by Value (2000-2009)
Figure: Cardiovascular Device Market by Geography in 2009
Figure: Global Cardiac Rhythm Management Market by Value (2007-2009)
Figure: Global Cardiovascular Market forecast by value (2009-2012)
Figure: US National Health Expenditures (2000-2009)
Figure: US Health Expenditures by Sectors in 2009
Figure: Deaths from Cardiovascular Diseases in US (2006)
Figure: US Cardiac Implant Market Forecast by Value (2009-2015E)
Figure: US Trade in Implantable Medical Devices (2004, 2008 & 2009)
Figure: US Number of cardiac Implant Procedures (2008, 2009 & 2012E)
Figure: North America, Major Players Market Share in Cardiovascular Device Industry in 2009
Figure: Urban per capita Disposable Income in China (1998-2007)
Figure: WW Aging Population within age group 55 to 80+ (1996-2010)
Figure: U.S. Population Obesity Analysis- % of obese (1995-2008)
Figure: US Neurostimulation Device Market (2007-2013)
Figure: Boston Scientific Revenues by Net Sales & Gross Profit (2009&2010)

List Of Tables

LIST OF TABLES

Table: US Prevalence of Cardiovascular Disease in Adults by Age and Sex (2003-2006)
Table: US Cardiovascular Disease Death Rates by Category and Sex in 2007
Table: Hong Kong Number of Registered Healthcare Professionals (March 31, 2008)
Table: Medtronic Inc Revenues by Business Segments (2009&2010)
Table: Boston Scientific Revenues by Geography (2007-2009)